犬尿氨酸
肿瘤微环境
癌症研究
吲哚胺2,3-双加氧酶
NAD+激酶
嘌呤能受体
封锁
免疫检查点
免疫系统
受体
药理学
生物
医学
内科学
免疫学
生物化学
酶
氨基酸
色氨酸
作者
Kunle O. Odunsi,Feng Qian,Amit Anand Lugade,Han Yu,Melissa Ann Geller,Steven P. Fling,Judith C. Kaiser,Andreanne M. Lacroix,Leonard D’Amico,Nirasha Ramchurren,Chihiro Morishima,Mary Lenora Disis,Lucas M. Dennis,Patrick J. Danaher,Sarah E. Warren,Van Anh Nguyen,Sudharshan Ravi,Takemasa Tsuji,Spencer R. Rosario,Wenjuan Zha
标识
DOI:10.1126/scitranslmed.abg8402
摘要
To uncover underlying mechanisms associated with failure of indoleamine 2,3-dioxygenase 1 (IDO1) blockade in clinical trials, we conducted a pilot, window-of-opportunity clinical study in 17 patients with newly diagnosed advanced high-grade serous ovarian cancer before their standard tumor debulking surgery. Patients were treated with the IDO1 inhibitor epacadostat, and immunologic, transcriptomic, and metabolomic characterization of the tumor microenvironment was undertaken in baseline and posttreatment tumor biopsies. IDO1 inhibition resulted in efficient blockade of the kynurenine pathway of tryptophan degradation and was accompanied by a metabolic adaptation that shunted tryptophan catabolism toward the serotonin pathway. This resulted in elevated nicotinamide adenine dinucleotide (NAD + ), which reduced T cell proliferation and function. Because NAD + metabolites could be ligands for purinergic receptors, we investigated the impact of blocking purinergic receptors in the presence or absence of NAD + on T cell proliferation and function in our mouse model. We demonstrated that A2a and A2b purinergic receptor antagonists, SCH58261 or PSB1115, respectively, rescued NAD + -mediated suppression of T cell proliferation and function. Combining IDO1 inhibition and A2a/A2b receptor blockade improved survival and boosted the antitumor immune signature in mice with IDO1 overexpressing ovarian cancer. These findings elucidate the downstream adaptive metabolic consequences of IDO1 blockade in ovarian cancers that may undermine antitumor T cell responses in the tumor microenvironment.
科研通智能强力驱动
Strongly Powered by AbleSci AI